Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing

Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system. The eQUANT system is a leap forward in combatting antibiotic resistance, providing a standardized inoculum (0.5 McFarland equivalent) directly from positive blood cultures. The clinical data submitted to FDA demonstrated eQ

Related Keywords

Stefan Riedel , Oren Knopfmacher , Beth Israel Deaconess Medical Center , Business Development , Avails Medical Inc , Associate Medical Director , Michael Blitz , Executive Vice President , Avails Medical , Medical , Nc , Antibiotic Resistance , Quant , Dust , Antibiotic Susceptibility ,